Skip to content
GLP-1 Savers
Provider review

Zealthy review

Value Score54/100

Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

By Grant Ashford, Founder & Pricing Editor

We earn a commission when you start treatment through some links on this site, at no extra cost to you. CoreAge Rx is a featured partner, and providers we work with may appear first. It never changes the Value Score.

Advertised price

From $286/mo

From $286/mo (starting dose, plus a separate fee, compounded)

FDA warning letter. The FDA issued FitRX, LLC dba Zealthy a warning letter in September 2025. Check it on the FDA database.

Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose, and the price is not shown until after you complete an intake.

How much does Zealthy cost?

Zealthy does not show this price on its public website, so confirm it during sign-up. The figure we have is From $286/mo (starting dose, plus a separate fee, compounded). Tirzepatide is listed at From $351/mo (starting dose, plus a separate fee, compounded). We flag this one to watch: confirm the ongoing rate with Zealthy before you count on it.

Semaglutide
From $286/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
From $351/mo (starting dose, plus a separate fee, compounded)
Coverage
34 states
Brand-name
Compounded only

The Value Score card

Zealthy scored on our six published factors. See the methodology.

Lowest Real Price55/100
No Teaser-Rate Bait30/100
Nationwide Availability72/100
Both Molecules92/100
Easy Cancellation54/100
Reputation25/100

What's good

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

Read the fine print

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers who want not currently recommended — listed for transparency and reader awareness only.

For comparison, see CoreAge Rx, a featured partner (Value Score 81/100).

Programs to compare

Compare with other deals

The programs scoring closest to Zealthy, out of 428 others we track.

Shopping Zealthy against a specific rival? We put it head to head with our featured partner on CoreAge Rx vs Zealthy, and every program that undercuts or outscores it — starting with Remedy Meds, the closest match on score — is ranked on the Zealthy alternatives ranking.

More programs we track (24)

395 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page come from Zealthy's own website; the Value Score is our editorial judgment per the methodology."% vs brand-name self-pay" compares a program's lowest disclosed monthly price against $349/mo, Wegovy's self-pay price at NovoCare Pharmacy, every standard dose after the two-month intro offer (checked October 2026). Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.

See the cheapest programs →

← Back to all deals